Advertisement

AJNR is seeking candidates for the AJNR Podcast Editor. Read the position description.

Index by author

March 01, 2013; Volume 34,Issue 3

  1. Abe, T.

    1. Interventional
      Superior Petrosal Sinus: Hemodynamic Features in Normal and Cavernous Sinus Dural Arteriovenous Fistulas
      R. Shimada, H. Kiyosue, S. Tanoue, H. Mori and T. Abe
      American Journal of Neuroradiology March 2013, 34 (3) 609-615; DOI: https://doi.org/10.3174/ajnr.A3252

  2. Agosta, F.

    1. Brain
      The Role of Amyloid-β, tau, and Apolipoprotein E ε4 in Alzheimer Disease: How Is the Team Playing?
      M. Filippi, E. Canu and F. Agosta
      American Journal of Neuroradiology March 2013, 34 (3) 511-512; DOI: https://doi.org/10.3174/ajnr.A3295

  3. Aisen, P.S.

    1. EDITOR'S CHOICEBrain
      Open Access
      Apolipoprotein E ε4 Does Not Modulate Amyloid-β–Associated Neurodegeneration in Preclinical Alzheimer Disease
      R.S. Desikan, L.K. McEvoy, D. Holland, W.K. Thompson, J.B. Brewer, P.S. Aisen, O.A. Andreassen, B.T. Hyman, R.A. Sperling, A.M. Dale and for the Alzheimer's Disease Neuroimaging Initiative
      American Journal of Neuroradiology March 2013, 34 (3) 505-510; DOI: https://doi.org/10.3174/ajnr.A3267

      These authors investigated the relationship between amyloid-β, phosphorylated tau, and apolipoprotein E in preclinical Alzheimer disease in 170 patients and controls who had serial imaging up to 3.5 years after the initial study. Global volumes as well as volumes in brain regions known to be involved in the chronic stages of the disease were assessed. Their results led them to propose that atrophy rates are primarily influenced by apolipoprotein E via amyloid-β mechanisms and that amyloid-β -associated neurodegeneration occurs only in the presence of phosphorylated tau.

  4. Ambarki, K.

    1. Brain
      Automated Determination of Brain Parenchymal Fraction in Multiple Sclerosis
      M. Vågberg, T. Lindqvist, K. Ambarki, J.B.M. Warntjes, P. Sundström, R. Birgander and A. Svenningsson
      American Journal of Neuroradiology March 2013, 34 (3) 498-504; DOI: https://doi.org/10.3174/ajnr.A3262

  5. Andreassen, O.A.

    1. EDITOR'S CHOICEBrain
      Open Access
      Apolipoprotein E ε4 Does Not Modulate Amyloid-β–Associated Neurodegeneration in Preclinical Alzheimer Disease
      R.S. Desikan, L.K. McEvoy, D. Holland, W.K. Thompson, J.B. Brewer, P.S. Aisen, O.A. Andreassen, B.T. Hyman, R.A. Sperling, A.M. Dale and for the Alzheimer's Disease Neuroimaging Initiative
      American Journal of Neuroradiology March 2013, 34 (3) 505-510; DOI: https://doi.org/10.3174/ajnr.A3267

      These authors investigated the relationship between amyloid-β, phosphorylated tau, and apolipoprotein E in preclinical Alzheimer disease in 170 patients and controls who had serial imaging up to 3.5 years after the initial study. Global volumes as well as volumes in brain regions known to be involved in the chronic stages of the disease were assessed. Their results led them to propose that atrophy rates are primarily influenced by apolipoprotein E via amyloid-β mechanisms and that amyloid-β -associated neurodegeneration occurs only in the presence of phosphorylated tau.

  6. Apostol, M.A.

    1. Spine
      CT-Guided Cervical Transforaminal Steroid Injections: Where Should the Needle Tip Be Located?
      J.K. Hoang, D.P. Massoglia, M.A. Apostol, C.D. Lascola, J.D. Eastwood and P.G. Kranz
      American Journal of Neuroradiology March 2013, 34 (3) 688-692; DOI: https://doi.org/10.3174/ajnr.A3266

  7. Arquizan, C.

    1. FELLOWS' JOURNAL CLUBInterventional
      Evaluation of an Intravenous-Endovascular Strategy in Patients with Acute Proximal Middle Cerebral Artery Occlusion
      J.-F. Vendrell, R. Mernes, N. Nagot, D. Milhaud, K. Lobotesis, V. Costalat, P. Machi, I.L. Maldonado, C. Riquelme, C. Arquizan and A. Bonafe
      American Journal of Neuroradiology March 2013, 34 (3) 603-608; DOI: https://doi.org/10.3174/ajnr.A3230

      Here, the safety and efficacy of mechanical thrombectomy after intravenous therapy failure were assessed in 123 patients with acute MCA occlusions. All patients imaged were within 4.5 hours of onset, had DWI ASPECTS greater than 5, and variable NIHSS scores (8–25). The authors found that mechanical thrombectomy after failure of intravenous thrombolysis improves clinical outcomes at 3 months and could represent an alternative in the management of patients with acute MCA occlusion. Additionally, no symptomatic intracranial hemorrhages were detected in patients treated this way, suggesting this protocol is safe.

Back to top

In this issue

Advertisement
Advertisement